188 related articles for article (PubMed ID: 23464817)
1. Invasive pneumococcal disease in patients with an underlying pulmonary disorder.
Inghammar M; Engström G; Kahlmeter G; Ljungberg B; Löfdahl CG; Egesten A
Clin Microbiol Infect; 2013 Dec; 19(12):1148-54. PubMed ID: 23464817
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and outcome of sepsis in adult patients with Streptococcus pneumoniae infection in a Norwegian county 1993-2011: an observational study.
Askim Å; Mehl A; Paulsen J; DeWan AT; Vestrheim DF; Åsvold BO; Damås JK; Solligård E
BMC Infect Dis; 2016 May; 16():223. PubMed ID: 27216810
[TBL] [Abstract][Full Text] [Related]
3. Invasive Pneumococcal Disease: Still Lots to Learn and a Need for Standardized Data Collection Instruments.
Marrie TJ; Tyrrell GJ; Majumdar SR; Eurich DT
Can Respir J; 2017; 2017():2397429. PubMed ID: 28424565
[No Abstract] [Full Text] [Related]
4. [Not Available].
Gillissen A
MMW Fortschr Med; 2023 Oct; 165(18):5. PubMed ID: 37828302
[No Abstract] [Full Text] [Related]
5. Redefining risk categories for pneumococcal disease in adults: critical analysis of the evidence.
Curcio D; Cané A; Isturiz R
Int J Infect Dis; 2015 Aug; 37():30-5. PubMed ID: 25997673
[TBL] [Abstract][Full Text] [Related]
6. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease.
Yildirim I; Shea KM; Little BA; Silverio AL; Pelton SI;
Pediatrics; 2015 Mar; 135(3):495-503. PubMed ID: 25647674
[TBL] [Abstract][Full Text] [Related]
7. Incidence of pneumococcal and varicella disease in HIV-infected children and adolescents in the United Kingdom and Ireland, 1996-2011.
Payne H; Judd A; Donegan K; Okike IO; Ladhani SN; Doerholt K; Heath PT
Pediatr Infect Dis J; 2015 Feb; 34(2):149-54. PubMed ID: 25036047
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal vaccine targeting strategy for older adults: customized risk profiling.
Balicer RD; Cohen CJ; Leibowitz M; Feldman BS; Brufman I; Roberts C; Hoshen M
Vaccine; 2014 Feb; 32(8):990-5. PubMed ID: 24384054
[TBL] [Abstract][Full Text] [Related]
9. Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales.
Ladhani SN; Andrews NJ; Waight P; Borrow R; Slack MP; Miller E
Clin Infect Dis; 2014 Feb; 58(4):517-25. PubMed ID: 24300040
[TBL] [Abstract][Full Text] [Related]
10. Risk of invasive pneumococcal disease in children and adults with asthma: a systematic review.
Boikos C; Quach C
Vaccine; 2013 Oct; 31(42):4820-6. PubMed ID: 23965221
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal vaccination in older adults in the era of childhood vaccination: Public health insights from a Norwegian statistical prediction study.
Steens A; Vestrheim DF; de Blasio BF
Epidemics; 2015 Jun; 11():24-31. PubMed ID: 25979279
[TBL] [Abstract][Full Text] [Related]
12. Editorial Commentary: The Story of Sisyphus: Why We Need a Universal Pneumococcal Vaccine to Replace Current Conjugate Vaccines.
Ladhani SN; Ramsay ME
Clin Infect Dis; 2015 Sep; 61(5):776-8. PubMed ID: 25972021
[No Abstract] [Full Text] [Related]
13. Prevalence and impact of Streptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study.
Thornton CS; Brown EL; Alcantara J; Rabin HR; Parkins MD
BMC Pulm Med; 2015 May; 15():49. PubMed ID: 25930152
[TBL] [Abstract][Full Text] [Related]
14. The serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease.
Flasche S; Le Polain de Waroux O; O'Brien KL; Edmunds WJ
PLoS Comput Biol; 2015 Apr; 11(4):e1004173. PubMed ID: 25879748
[TBL] [Abstract][Full Text] [Related]
15. Immunodeficiency among children with recurrent invasive pneumococcal disease.
Ingels H; Schejbel L; Lundstedt AC; Jensen L; Laursen IA; Ryder LP; Heegaard NH; Konradsen H; Christensen JJ; Heilmann C; Marquart HV
Pediatr Infect Dis J; 2015 Jun; 34(6):644-51. PubMed ID: 25831419
[TBL] [Abstract][Full Text] [Related]
16. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
[TBL] [Abstract][Full Text] [Related]
17. Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia.
Rodrigo C; Bewick T; Sheppard C; Greenwood S; Mckeever TM; Trotter CL; Slack M; George R; Lim WS
Eur Respir J; 2015 Jun; 45(6):1632-41. PubMed ID: 25792633
[TBL] [Abstract][Full Text] [Related]
18. MDCT evaluation of early pulmonary infection types after liver transplantation.
Hekimoglu K; Tezcan S; Coskun M; Dogrul MI; Moray G; Haberal M
Transplant Proc; 2015 Mar; 47(2):473-7. PubMed ID: 25769594
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for death from invasive pneumococcal disease, Europe, 2010.
Navarro-Torné A; Dias JG; Hruba F; Lopalco PL; Pastore-Celentano L; Gauci AJ;
Emerg Infect Dis; 2015 Mar; 21(3):417-25. PubMed ID: 25693604
[TBL] [Abstract][Full Text] [Related]
20. ALAT-2014 Chronic Obstructive Pulmonary Disease (COPD) Clinical Practice Guidelines: questions and answers.
Montes de Oca M; López Varela MV; Acuña A; Schiavi E; Rey MA; Jardim J; Casas A; Tokumoto A; Torres Duque CA; Ramírez-Venegas A; García G; Stirbulov R; Camelier A; Bergna M; Cohen M; Guzmán S; Sánchez E
Arch Bronconeumol; 2015 Aug; 51(8):403-16. PubMed ID: 25596991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
